A five-drug combination, including metoclopramide, thiethylperazine, diphenhydramine, dexamethasone, and diazepam, was given to 32 patients during three consecutive treatments with chemotherapy. Eighteen patients (group A) were treated with a cisplatin-containing regimen, and 14 patients (group B) were treated with a cyclophosphamide- and doxorubicin-containing chemotherapy. In group A, complete responses were lower on the first day than on the second and third days (P < 0.015 and P < 0.041, respectively), during the first and second courses. The five-drug antiemetic regimen seems safe and effective. These results show that clinical trials that evaluate antiemetic efficacy in cisplatin-containing chemotherapy regimens should evaluate at lea...
Nausea and vomiting are extremely common and most distressing side effects of high-dose cisplatin th...
Important progress has been achieved in the last few years in the prevention of chemotherapy-induced...
Repeated oral doses of metoclopramide (50 mg) and prednisone (25 mg) completely prevented nausea and...
Forty patients receiving a total of 102 courses of cisplatin (CDDP)-based treatment were observed in...
We compared the antiemetic efficacy of metoclopramide in a bolus low-dose infusion schedule to that ...
We report a single-blind randomized crossover trial comparing the efficacy of tropisetron plus dexam...
The results of an open study designed to evaluate the prevention of cisplatin-induced emesis by the ...
Two controlled double-blind studies were carried out successively on a cancerous out-patient populat...
This study was conducted to evaluate the efficacy of diazepam in managing acute and delayed emesis i...
The purpose of this study was to compare the antiemetic efficacy of three 5-HT3 antagonists (granise...
A phase III, single-institution, open, prospective, randomized, parallel study was carried out on he...
Introduction of cisplatin based chemotherapy has revolutionized the treatment of germ cell tumors. A...
The emetogenic potential of cancer chemotherapeutic agents varies according to the agent employed. A...
Background: This study examined whether different ondansetron dosing schedules plus dexamethasone in...
Ondansetron (OND) is a new 5-HT3 receptor antagonist that give complete protection from emesis/nause...
Nausea and vomiting are extremely common and most distressing side effects of high-dose cisplatin th...
Important progress has been achieved in the last few years in the prevention of chemotherapy-induced...
Repeated oral doses of metoclopramide (50 mg) and prednisone (25 mg) completely prevented nausea and...
Forty patients receiving a total of 102 courses of cisplatin (CDDP)-based treatment were observed in...
We compared the antiemetic efficacy of metoclopramide in a bolus low-dose infusion schedule to that ...
We report a single-blind randomized crossover trial comparing the efficacy of tropisetron plus dexam...
The results of an open study designed to evaluate the prevention of cisplatin-induced emesis by the ...
Two controlled double-blind studies were carried out successively on a cancerous out-patient populat...
This study was conducted to evaluate the efficacy of diazepam in managing acute and delayed emesis i...
The purpose of this study was to compare the antiemetic efficacy of three 5-HT3 antagonists (granise...
A phase III, single-institution, open, prospective, randomized, parallel study was carried out on he...
Introduction of cisplatin based chemotherapy has revolutionized the treatment of germ cell tumors. A...
The emetogenic potential of cancer chemotherapeutic agents varies according to the agent employed. A...
Background: This study examined whether different ondansetron dosing schedules plus dexamethasone in...
Ondansetron (OND) is a new 5-HT3 receptor antagonist that give complete protection from emesis/nause...
Nausea and vomiting are extremely common and most distressing side effects of high-dose cisplatin th...
Important progress has been achieved in the last few years in the prevention of chemotherapy-induced...
Repeated oral doses of metoclopramide (50 mg) and prednisone (25 mg) completely prevented nausea and...